TIDMAPH

RNS Number : 2246A

Alliance Pharma PLC

18 December 2014

 
 For Immediate Release                          18 December 2014

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Directorate Change

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, confirms that, further to the announcement on 30 December 2013, Paul Ranson will retire from his position as Non-Executive Director of the Company on 31 December 2014.

For further information:

 
 Alliance Pharma plc                    + 44 (0) 1249 466966 
 John Dawson, Chief Executive 
 Richard Wright, Finance Director 
 www.alliancepharma.co.uk 
 Buchanan                              + 44 (0) 20 7466 5000 
 Mark Court / Sophie Cowles / Jane 
  Glover 
 
 Numis Securities Limited              + 44 (0) 20 7260 1000 
 Nominated Adviser: Michael Meade / 
  Freddie Barnfield 
 Corporate Broking: David Poutney

Notes to editors:

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOAZMMMZKRFGDZM

Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Alliance Pharma Charts.
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Alliance Pharma Charts.